Sign in

    Page Taggart

    Managing Director and Senior Analyst at APT Capital

    Page Taggart is a Managing Director and Senior Analyst at APT Capital, specializing in equity research within the consumer and retail sectors. Taggart provides in-depth coverage of leading companies such as Walmart, Target, Costco, and Dollar General, earning a reputation for keen market insights and accurate earnings forecasts. Over a career beginning in the early 2000s, Page has held key research roles at UBS and Oppenheimer before joining APT Capital in 2018, consistently ranking among the top analysts on performance tracking platforms with a documented success rate near 65% and double-digit average annualized returns for recommended stocks. Taggart holds FINRA Series 7, 63, and 86/87 licenses and has been recognized for notable industry achievements, including multiple awards for research excellence.

    Page Taggart's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership

    Page Taggart's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership • Q3 2024

    Question

    Page Taggart of APT Capital requested more detail on the distribution channel with Venture Medical, focusing specifically on the sales cycle.

    Answer

    Jason Matuszewski, Founder and CEO, described a lean, daily ordering and fulfillment process with Venture Medical. He highlighted that weekly demand pipeline meetings and Venture's 'Venture OneView' platform provide insight into product needs based on wound progression, allowing BioStem to manage manufacturing and production effectively.

    Ask Fintool Equity Research AI